1,374 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
NVS Novartis AG $85.13 $197.65B N/A
Article Searches
SBM Offshore NV ADR declares $0.23 dividend https://seekingalpha.com/news/3257097-sbm-offshore-nv-adr-declares-0_23-dividend?source=feed_news_all Apr 13, 2017 - SBM Offshore NV ADR (OTCPK:SBFFY) declares $0.23/share annual dividend, 8.5% increase from prior dividend of $0.212.Forward yield 1.39%Payable May 12; for shareholders of record April 20; ex-div April
Why Juno Therapeutics' Stock Tumbled in the Past One Year http://www.zacks.com/stock/news/256376/why-juno-therapeutics-stock-tumbled-in-the-past-one-year?cid=CS-ZC-FT-256376 Apr 13, 2017 - Juno Therapeutics, Inc.'s (JUNO) stock has significantly underperformed Zacks classified Medical-Biomed/Genetics industry in the past one year.
IntelliPharmaCeutics (IPCI) Q1 Loss Narrower Than Expected http://www.zacks.com/stock/news/256374/intellipharmaceutics-ipci-q1-loss-narrower-than-expected?cid=CS-ZC-FT-256374 Apr 13, 2017 - IntelliPharmaCeutics International Inc. (IPCI) reported loss of 7 cents per share in the first quarter of 2017, narrower than both the Zacks Consensus Estimate of a loss of 8 cents and the year-ago loss of 9 cents per share.
First American Bank Buys JPMorgan Chase, Medtronic PLC, Exelon, Sells NXP Semiconductors NV, ... http://www.gurufocus.com/news/502612/first-american-bank-buys-jpmorgan-chase-medtronic-plc-exelon-sells-nxp-semiconductors-nv-edwards-lifesciences-domtar Apr 11, 2017 - First American Bank Buys JPMorgan Chase, Medtronic PLC, Exelon, Sells NXP Semiconductors NV, Edwards Lifesciences, Domtar, Stocks: JPM,MDT,BA,AMZN,UNH,ETR,EXC,RY,IBM,VEA,LCII,CC,NXP, release date:Apr 11, 2017
Endo (ENDP) Reports Preliminary Results for First Quarter http://www.zacks.com/stock/news/256087/endo-endp-reports-preliminary-results-for-first-quarter?cid=CS-ZC-FT-256087 Apr 11, 2017 - Endo International plc (ENDP) recently announced preliminary results for first-quarter 2017.
Forget Novartis, Buy These Two Pharma Stocks Instead http://www.zacks.com/stock/news/255998/forget-novartis-buy-these-two-pharma-stocks-instead?cid=CS-ZC-FT-255998 Apr 11, 2017 - With Novartis (NVS) being a Zacks Rank #4 (Sell) stock, here is a look at two European pharma stocks that sport a strong Zacks Rank.
Sheets Smith Wealth Management Buys Stericycle, Citigroup, Chicago Bridge & Iron Co NV, ... http://www.gurufocus.com/news/502022/sheets-smith-wealth-management-buys-stericycle-citigroup-chicago-bridge--iron-co-nv-sells-papa-johns-international-us-ecology-us-bancorp Apr 10, 2017 -
Roche's Lung Cancer Drug Alecensa Meets Primary Endpoint http://www.zacks.com/stock/news/255925/roches-lung-cancer-drug-alecensa-meets-primary-endpoint?cid=CS-ZC-FT-255925 Apr 10, 2017 - Roche (RHHBY) announced that the global, randomized phase III study, ALEX, on lung cancer drug Alecensa met its primary endpoint as an initial (first-line) treatment.
Nepsis Capital Management, Inc. Buys STMicroelectronics NV, Cisco Systems, ArcelorMittal SA, ... http://www.gurufocus.com/news/500926/nepsis-capital-management-inc-buys-stmicroelectronics-nv-cisco-systems-arcelormittal-sa-sells-nutanix-walmart-stores-ventas Apr 07, 2017 - Nepsis Capital Management, Inc. Buys STMicroelectronics NV, Cisco Systems, ArcelorMittal SA, Sells Nutanix, Wal-Mart Stores, Ventas, Stocks: RIO,FFIV,STM,CSCO,MT,TWLO,CHKP,AXS,NTNX,WMT,AIRG,, release date:Apr 07, 2017
Pharma Stock Roundup: FDA Nod for SNY, Roche Drugs, Generic Advair Relief for GSK? http://www.zacks.com/stock/news/254783/pharma-stock-roundup-fda-nod-for-sny-roche-drugs-generic-advair-relief-for-gsk?cid=CS-ZC-FT-254783 Mar 31, 2017 - Two drugs with blockbuster potential - Sanofi (SNY)/Regeneron's Dupixent and Roche's Ocrevus - gained FDA approval this week.
<<<Page 126>